These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6177931)

  • 1. Hypotensive effect of the hydralazine--acetone hydrazone in conscious rabbits: evidence for its back-conversion to hydralazine in vivo.
    Talseth T; McNay JL; Haegele KD
    J Cardiovasc Pharmacol; 1982; 4(3):370-4. PubMed ID: 6177931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous generation of hydralazine from labile hydralazine hydrazones.
    Clementi WA; McNay JL; Talseth T; Haegele KD; Ludden TM; Musgrave GE
    J Pharmacol Exp Ther; 1982 Jul; 222(1):159-65. PubMed ID: 7086698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone.
    Talseth T; Haegele KD; McNay JL; Skrdlant HB; Clementi WA; Shepherd AM
    J Pharmacol Exp Ther; 1979 Dec; 211(3):509-13. PubMed ID: 512915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and biotransformation of hydralazine acetone hydrazone, a metabolite of hydralazine, in the rat.
    Iwaki M; Ogiso T; Ito Y
    J Pharm Sci; 1989 Oct; 78(10):867-73. PubMed ID: 2600796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro kinetic studies of the reaction of hydralazine and its acetone hydrazone with pyruvic acid.
    Iwaki M; Ogiso T; Ito Y
    J Pharm Sci; 1988 Mar; 77(3):280-3. PubMed ID: 3373434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of formation and excretion of some metabolites of hydralazine and their hypotensive effect in rats.
    Ogiso T; Iwaki M; Ohtsuki N
    J Pharmacol Exp Ther; 1985 May; 233(2):485-90. PubMed ID: 3999031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference in assays for hydralazine in humans by a major plasma metabolite, hydralazine pyruvic acid hydrazone.
    Reece PA; Stanley PE; Zacest R
    J Pharm Sci; 1978 Aug; 67(8):1150-3. PubMed ID: 27629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydralazine and its metabolites: in vitro and in vivo activity in the rat.
    Criscione L; Eichenberger K; Hedwall PR; Schmid K
    J Cardiovasc Pharmacol; 1986; 8(2):420-7. PubMed ID: 2422484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteers.
    Reece PA; Stafford I; Prager RH; Walker GJ; Zacest R
    J Pharm Sci; 1985 Feb; 74(2):193-6. PubMed ID: 3989691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in the rabbit on 3-methyltriazolophthalazine, an acetylated metabolite of hydralazine. Evidence for an alternative route of formation.
    Talseth T; Haegele KD; McNay JL
    Drug Metab Dispos; 1980; 8(2):73-6. PubMed ID: 6103791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine.
    Haegele KD; Skrdlant HB; Talseth T; McNay JL; Shepherd AM; Clementi WA
    J Chromatogr; 1980 Jan; 187(1):171-9. PubMed ID: 7358814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans.
    Shepherd AM; Ludden TM; Haegele KD; Talseth T; McNay JL
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):129-44. PubMed ID: 515498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Route and rate of hydrallazine administration as determinants to its hypotensive effect in rabbits.
    Talseth T; McNay JL; Clementi WA
    Clin Exp Pharmacol Physiol; 1980 Jul; 7(4):403-6. PubMed ID: 7418274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of hydralazine and hydrazone derivatives with contractile mechanisms in rabbit aortic smooth muscle.
    McLean AJ; Barron K; du Souich P; Haegele KD; McNay JL; Carrier O; Briggs A
    J Pharmacol Exp Ther; 1978 May; 205(2):418-25. PubMed ID: 641837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of hydralazine pyruvic acid hydrazone and its correlation with "apparent" hydralazine.
    Haegele KD; Talseth T; Skrdlant HB; Shepherd AM; Huff SL
    Arzneimittelforschung; 1981; 31(2):357-62. PubMed ID: 7194654
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs.
    Konno K; Nonaka K; Ueno A
    Arzneimittelforschung; 1981; 31(7):1072-5. PubMed ID: 7196755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
    Bolt GR; Saxena PR
    J Pharmacol Exp Ther; 1984 Jul; 230(1):205-13. PubMed ID: 6747826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of budralazine, a new antihypertensive agent, III.
    Ono K; Saito T; Sasano H; Moroi R; Sano M; Akimoto T
    Xenobiotica; 1979 Apr; 9(4):227-36. PubMed ID: 483859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydralazine and related compounds: chemistry, metabolism, and mode of action.
    Reece PA
    Med Res Rev; 1981; 1(1):73-96. PubMed ID: 7050561
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.